Categories: News

Ajay Dhankhar Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

NEW YORK–(BUSINESS WIRE)–Lazard Ltd (NYSE: LAZ) announced today that Ajay Dhankhar has joined the firm as a Managing Director in the Healthcare Group within Financial Advisory, effective immediately. Based in New York, Mr. Dhankhar will serve as Global Head of Medical Technology, Diagnostics and Tools. He will also advise clients in other healthcare segments, including biopharmaceuticals, and healthcare information and technology.

“Ajay brings deep experience to our Healthcare practice as a trusted strategic advisor to C-suite executives and boards,” said David Gluckman, Global Head of the Healthcare Group at Lazard. “The healthcare sector, including medical devices and technology, is experiencing strong growth that is set to continue in the years ahead. Adding a seasoned healthcare advisor like Ajay will ensure Lazard continues to provide clients with the very best possible advice.”

Mr. Dhankhar is a former biochemist and a highly experienced healthcare advisor, with particular expertise in the fields of medical technology, diagnostics and tools, and biopharmaceuticals. He is an established thought leader, espousing the concept that portfolio optimization through M&A, joint ventures and divestments, when coupled with rational capital allocation, can help companies deliver sector- and industry-leading shareholder value.

Mr. Dhankhar has advised on more than 50 major transactions, including four of the 10 largest mergers and/or restructurings to have taken place in the life sciences industry in recent years. He joins Lazard from McKinsey & Company, where he was a Senior Partner and Global Leader of the firm’s Life Sciences Strategy, M&A, Corporate Finance and Enterprise Risk practices. He previously served as Global Leader of McKinsey’s Life Sciences R&D practice.

Mr. Dhankhar has a bachelor’s degree in Physics and Computer Science from Angelo State University and both a master’s degree and a doctorate in Molecular Biophysics and Biochemistry from Yale University.

About Lazard

Lazard, one of the world’s preeminent financial advisory and asset management firms, operates from 40 cities across 25 countries in North and South America, Europe, Asia and Australia. With origins dating to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments and individuals. For more information on Lazard, please visit www.lazard.com. Follow Lazard at @Lazard

LAZ_FAPE 

Contacts

Media Contact:

Judi Frost Mackey, +1 212 632 1428

judi.mackey@lazard.com

Investor Contact:

Alexandra Deignan, +1 212 632 6886

alexandra.deignan@lazard.com

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago